nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—CYP1A2—type 2 diabetes mellitus	0.223	0.602	CbGaD
Albendazole—CYP3A4—type 2 diabetes mellitus	0.147	0.398	CbGaD
Albendazole—ABCB1—Linagliptin—type 2 diabetes mellitus	0.041	0.104	CbGbCtD
Albendazole—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0366	0.0928	CbGbCtD
Albendazole—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0279	0.0708	CbGbCtD
Albendazole—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0264	0.0671	CbGbCtD
Albendazole—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0246	0.0624	CbGbCtD
Albendazole—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.022	0.0557	CbGbCtD
Albendazole—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0219	0.0556	CbGbCtD
Albendazole—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0208	0.0527	CbGbCtD
Albendazole—CYP3A4—Glipizide—type 2 diabetes mellitus	0.02	0.0508	CbGbCtD
Albendazole—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0182	0.0461	CbGbCtD
Albendazole—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0175	0.0444	CbGbCtD
Albendazole—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0158	0.0402	CbGbCtD
Albendazole—CYP1A2—Losartan—type 2 diabetes mellitus	0.0142	0.0359	CbGbCtD
Albendazole—ABCB1—Glyburide—type 2 diabetes mellitus	0.0135	0.0343	CbGbCtD
Albendazole—ABCB1—Losartan—type 2 diabetes mellitus	0.0124	0.0314	CbGbCtD
Albendazole—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.012	0.0305	CbGbCtD
Albendazole—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0115	0.0292	CbGbCtD
Albendazole—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0115	0.0292	CbGbCtD
Albendazole—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0109	0.0276	CbGbCtD
Albendazole—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00811	0.0206	CbGbCtD
Albendazole—CYP3A4—Losartan—type 2 diabetes mellitus	0.00742	0.0188	CbGbCtD
Albendazole—TUBA1A—peripheral nervous system—type 2 diabetes mellitus	0.00485	0.146	CbGeAlD
Albendazole—TUBA1A—nerve—type 2 diabetes mellitus	0.00378	0.114	CbGeAlD
Albendazole—TUBA1A—islet of Langerhans—type 2 diabetes mellitus	0.00183	0.0553	CbGeAlD
Albendazole—TUBA1A—retina—type 2 diabetes mellitus	0.00157	0.0473	CbGeAlD
Albendazole—TUBA1A—nephron tubule—type 2 diabetes mellitus	0.00148	0.0445	CbGeAlD
Albendazole—TUBA1A—cardiovascular system—type 2 diabetes mellitus	0.00132	0.04	CbGeAlD
Albendazole—TUBA1A—kidney—type 2 diabetes mellitus	0.0013	0.0391	CbGeAlD
Albendazole—TUBA1A—pancreas—type 2 diabetes mellitus	0.00129	0.0389	CbGeAlD
Albendazole—TUBA1A—cortex of kidney—type 2 diabetes mellitus	0.00126	0.0381	CbGeAlD
Albendazole—TUBB4B—islet of Langerhans—type 2 diabetes mellitus	0.00122	0.0369	CbGeAlD
Albendazole—TUBA1A—adipose tissue—type 2 diabetes mellitus	0.00117	0.0353	CbGeAlD
Albendazole—TUBB4B—retina—type 2 diabetes mellitus	0.00104	0.0315	CbGeAlD
Albendazole—TUBB4B—nephron tubule—type 2 diabetes mellitus	0.000983	0.0297	CbGeAlD
Albendazole—TUBB4B—cardiovascular system—type 2 diabetes mellitus	0.000883	0.0267	CbGeAlD
Albendazole—TUBB4B—kidney—type 2 diabetes mellitus	0.000864	0.0261	CbGeAlD
Albendazole—TUBB4B—pancreas—type 2 diabetes mellitus	0.000858	0.0259	CbGeAlD
Albendazole—TUBB4B—cortex of kidney—type 2 diabetes mellitus	0.000841	0.0254	CbGeAlD
Albendazole—TUBA1A—liver—type 2 diabetes mellitus	0.000819	0.0247	CbGeAlD
Albendazole—TUBB4B—adipose tissue—type 2 diabetes mellitus	0.000779	0.0235	CbGeAlD
Albendazole—TUBB4B—liver—type 2 diabetes mellitus	0.000546	0.0165	CbGeAlD
Albendazole—CYP1A1—kidney—type 2 diabetes mellitus	0.000484	0.0146	CbGeAlD
Albendazole—Headache—Tolbutamide—type 2 diabetes mellitus	0.000448	0.00309	CcSEcCtD
Albendazole—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.000444	0.00306	CcSEcCtD
Albendazole—Liver function test abnormal—Irbesartan—type 2 diabetes mellitus	0.000443	0.00305	CcSEcCtD
Albendazole—Hepatobiliary disease—Gliclazide—type 2 diabetes mellitus	0.000443	0.00305	CcSEcCtD
Albendazole—Vertigo—Sitagliptin—type 2 diabetes mellitus	0.000442	0.00305	CcSEcCtD
Albendazole—Leukopenia—Glimepiride—type 2 diabetes mellitus	0.000442	0.00304	CcSEcCtD
Albendazole—Agranulocytosis—Gliclazide—type 2 diabetes mellitus	0.000437	0.00301	CcSEcCtD
Albendazole—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000436	0.0132	CbGeAlD
Albendazole—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000431	0.00296	CcSEcCtD
Albendazole—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000431	0.00296	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Pioglitazone—type 2 diabetes mellitus	0.000429	0.00295	CcSEcCtD
Albendazole—Gastrointestinal pain—Repaglinide—type 2 diabetes mellitus	0.000427	0.00294	CcSEcCtD
Albendazole—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000425	0.00293	CcSEcCtD
Albendazole—Thrombocytopenia—Glipizide—type 2 diabetes mellitus	0.000423	0.00291	CcSEcCtD
Albendazole—Hepatitis—Gliclazide—type 2 diabetes mellitus	0.00042	0.00289	CcSEcCtD
Albendazole—Renal failure acute—Ramipril—type 2 diabetes mellitus	0.000419	0.00289	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Sitagliptin—type 2 diabetes mellitus	0.000416	0.00287	CcSEcCtD
Albendazole—Urticaria—Repaglinide—type 2 diabetes mellitus	0.000415	0.00286	CcSEcCtD
Albendazole—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.000414	0.00285	CcSEcCtD
Albendazole—Alopecia—Glyburide—type 2 diabetes mellitus	0.000413	0.00285	CcSEcCtD
Albendazole—Abdominal pain—Repaglinide—type 2 diabetes mellitus	0.000413	0.00284	CcSEcCtD
Albendazole—Neutropenia—Metformin—type 2 diabetes mellitus	0.000411	0.00283	CcSEcCtD
Albendazole—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00041	0.00283	CcSEcCtD
Albendazole—Rash—Tolazamide—type 2 diabetes mellitus	0.00041	0.00283	CcSEcCtD
Albendazole—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000408	0.00281	CcSEcCtD
Albendazole—Headache—Tolazamide—type 2 diabetes mellitus	0.000408	0.00281	CcSEcCtD
Albendazole—Rash—Linagliptin—type 2 diabetes mellitus	0.000406	0.0028	CcSEcCtD
Albendazole—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.000406	0.00279	CcSEcCtD
Albendazole—Headache—Linagliptin—type 2 diabetes mellitus	0.000404	0.00278	CcSEcCtD
Albendazole—Skin disorder—Pioglitazone—type 2 diabetes mellitus	0.000402	0.00277	CcSEcCtD
Albendazole—Hepatobiliary disease—Orlistat—type 2 diabetes mellitus	0.000402	0.00277	CcSEcCtD
Albendazole—Vertigo—Bromocriptine—type 2 diabetes mellitus	0.0004	0.00276	CcSEcCtD
Albendazole—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000399	0.00275	CcSEcCtD
Albendazole—Vomiting—Acarbose—type 2 diabetes mellitus	0.000398	0.00274	CcSEcCtD
Albendazole—Erythema multiforme—Gliclazide—type 2 diabetes mellitus	0.000397	0.00273	CcSEcCtD
Albendazole—Thrombocytopenia—Glimepiride—type 2 diabetes mellitus	0.000395	0.00272	CcSEcCtD
Albendazole—Rash—Acarbose—type 2 diabetes mellitus	0.000394	0.00272	CcSEcCtD
Albendazole—Dermatitis—Acarbose—type 2 diabetes mellitus	0.000394	0.00271	CcSEcCtD
Albendazole—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.000392	0.0027	CcSEcCtD
Albendazole—Skin disorder—Sitagliptin—type 2 diabetes mellitus	0.00039	0.00269	CcSEcCtD
Albendazole—Neutropenia—Irbesartan—type 2 diabetes mellitus	0.000388	0.00267	CcSEcCtD
Albendazole—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000387	0.00266	CcSEcCtD
Albendazole—Nausea—Tolazamide—type 2 diabetes mellitus	0.000387	0.00266	CcSEcCtD
Albendazole—Hepatitis—Valsartan—type 2 diabetes mellitus	0.000386	0.00266	CcSEcCtD
Albendazole—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.000385	0.00265	CcSEcCtD
Albendazole—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000383	0.00264	CcSEcCtD
Albendazole—Hepatitis—Orlistat—type 2 diabetes mellitus	0.000381	0.00263	CcSEcCtD
Albendazole—Urinary tract disorder—Valsartan—type 2 diabetes mellitus	0.000381	0.00262	CcSEcCtD
Albendazole—Rash—Nateglinide—type 2 diabetes mellitus	0.00038	0.00262	CcSEcCtD
Albendazole—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00038	0.00262	CcSEcCtD
Albendazole—Urethral disorder—Valsartan—type 2 diabetes mellitus	0.000378	0.0026	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Bromocriptine—type 2 diabetes mellitus	0.000377	0.00259	CcSEcCtD
Albendazole—Urinary tract disorder—Orlistat—type 2 diabetes mellitus	0.000377	0.00259	CcSEcCtD
Albendazole—Urethral disorder—Orlistat—type 2 diabetes mellitus	0.000374	0.00257	CcSEcCtD
Albendazole—Nausea—Acarbose—type 2 diabetes mellitus	0.000372	0.00256	CcSEcCtD
Albendazole—Hepatobiliary disease—Metformin—type 2 diabetes mellitus	0.00037	0.00255	CcSEcCtD
Albendazole—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000365	0.00251	CcSEcCtD
Albendazole—Nausea—Nateglinide—type 2 diabetes mellitus	0.000358	0.00247	CcSEcCtD
Albendazole—Liver function test abnormal—Ramipril—type 2 diabetes mellitus	0.000357	0.00246	CcSEcCtD
Albendazole—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000355	0.0107	CbGeAlD
Albendazole—CYP3A4—kidney—type 2 diabetes mellitus	0.000355	0.0107	CbGeAlD
Albendazole—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000353	0.00243	CcSEcCtD
Albendazole—Gastrointestinal pain—Glipizide—type 2 diabetes mellitus	0.000353	0.00243	CcSEcCtD
Albendazole—Hepatitis—Metformin—type 2 diabetes mellitus	0.000351	0.00242	CcSEcCtD
Albendazole—Hepatobiliary disease—Irbesartan—type 2 diabetes mellitus	0.000349	0.00241	CcSEcCtD
Albendazole—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000349	0.0024	CcSEcCtD
Albendazole—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000345	0.00237	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Losartan—type 2 diabetes mellitus	0.000345	0.00237	CcSEcCtD
Albendazole—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000344	0.00237	CcSEcCtD
Albendazole—Urticaria—Glipizide—type 2 diabetes mellitus	0.000343	0.00236	CcSEcCtD
Albendazole—Abdominal pain—Glipizide—type 2 diabetes mellitus	0.000341	0.00235	CcSEcCtD
Albendazole—Alopecia—Valsartan—type 2 diabetes mellitus	0.000341	0.00235	CcSEcCtD
Albendazole—Alopecia—Orlistat—type 2 diabetes mellitus	0.000337	0.00232	CcSEcCtD
Albendazole—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000332	0.00229	CcSEcCtD
Albendazole—Hepatitis—Irbesartan—type 2 diabetes mellitus	0.000332	0.00228	CcSEcCtD
Albendazole—Gastrointestinal pain—Glimepiride—type 2 diabetes mellitus	0.00033	0.00227	CcSEcCtD
Albendazole—Rash—Repaglinide—type 2 diabetes mellitus	0.000329	0.00227	CcSEcCtD
Albendazole—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000329	0.00226	CcSEcCtD
Albendazole—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000329	0.00226	CcSEcCtD
Albendazole—Gastrointestinal pain—Sitagliptin—type 2 diabetes mellitus	0.000329	0.00226	CcSEcCtD
Albendazole—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000328	0.00226	CcSEcCtD
Albendazole—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000327	0.00225	CcSEcCtD
Albendazole—Headache—Repaglinide—type 2 diabetes mellitus	0.000327	0.00225	CcSEcCtD
Albendazole—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000326	0.00225	CcSEcCtD
Albendazole—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000325	0.00224	CcSEcCtD
Albendazole—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000325	0.00224	CcSEcCtD
Albendazole—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000325	0.00223	CcSEcCtD
Albendazole—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00032	0.0022	CcSEcCtD
Albendazole—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000319	0.0022	CcSEcCtD
Albendazole—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000319	0.00219	CcSEcCtD
Albendazole—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000318	0.00219	CcSEcCtD
Albendazole—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000318	0.00219	CcSEcCtD
Albendazole—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000318	0.00219	CcSEcCtD
Albendazole—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000317	0.00219	CcSEcCtD
Albendazole—Neutropenia—Ramipril—type 2 diabetes mellitus	0.000313	0.00215	CcSEcCtD
Albendazole—Hepatitis—Losartan—type 2 diabetes mellitus	0.000312	0.00215	CcSEcCtD
Albendazole—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000311	0.00214	CcSEcCtD
Albendazole—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000311	0.00214	CcSEcCtD
Albendazole—Nausea—Repaglinide—type 2 diabetes mellitus	0.00031	0.00213	CcSEcCtD
Albendazole—CYP1A2—liver—type 2 diabetes mellitus	0.00031	0.00936	CbGeAlD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000309	0.00213	CcSEcCtD
Albendazole—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000309	0.00213	CcSEcCtD
Albendazole—CYP1A1—liver—type 2 diabetes mellitus	0.000306	0.00923	CbGeAlD
Albendazole—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000305	0.0021	CcSEcCtD
Albendazole—ABCB1—retina—type 2 diabetes mellitus	0.000304	0.00916	CbGeAlD
Albendazole—Vertigo—Valsartan—type 2 diabetes mellitus	0.000302	0.00208	CcSEcCtD
Albendazole—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.0003	0.00206	CcSEcCtD
Albendazole—Vertigo—Orlistat—type 2 diabetes mellitus	0.000298	0.00205	CcSEcCtD
Albendazole—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000297	0.00205	CcSEcCtD
Albendazole—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000297	0.00204	CcSEcCtD
Albendazole—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000296	0.00204	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	0.000296	0.00204	CcSEcCtD
Albendazole—Erythema multiforme—Losartan—type 2 diabetes mellitus	0.000295	0.00203	CcSEcCtD
Albendazole—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000293	0.00202	CcSEcCtD
Albendazole—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000292	0.00201	CcSEcCtD
Albendazole—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.00029	0.002	CcSEcCtD
Albendazole—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000289	0.00199	CcSEcCtD
Albendazole—Mebendazole—CYP3A4—type 2 diabetes mellitus	0.000289	1	CrCbGaD
Albendazole—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000287	0.00198	CcSEcCtD
Albendazole—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000287	0.00198	CcSEcCtD
Albendazole—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000286	0.00863	CbGeAlD
Albendazole—Dizziness—Glipizide—type 2 diabetes mellitus	0.000286	0.00197	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000284	0.00196	CcSEcCtD
Albendazole—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000282	0.00194	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000281	0.00193	CcSEcCtD
Albendazole—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000278	0.00192	CcSEcCtD
Albendazole—Alopecia—Losartan—type 2 diabetes mellitus	0.000276	0.0019	CcSEcCtD
Albendazole—Vomiting—Glipizide—type 2 diabetes mellitus	0.000275	0.00189	CcSEcCtD
Albendazole—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000274	0.00188	CcSEcCtD
Albendazole—Rash—Glipizide—type 2 diabetes mellitus	0.000272	0.00187	CcSEcCtD
Albendazole—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000272	0.00187	CcSEcCtD
Albendazole—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000272	0.00187	CcSEcCtD
Albendazole—Headache—Glipizide—type 2 diabetes mellitus	0.000271	0.00186	CcSEcCtD
Albendazole—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000268	0.00185	CcSEcCtD
Albendazole—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000268	0.00184	CcSEcCtD
Albendazole—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000267	0.00183	CcSEcCtD
Albendazole—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000266	0.00183	CcSEcCtD
Albendazole—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000266	0.00183	CcSEcCtD
Albendazole—Urticaria—Glyburide—type 2 diabetes mellitus	0.000264	0.00182	CcSEcCtD
Albendazole—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000263	0.00181	CcSEcCtD
Albendazole—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000263	0.00181	CcSEcCtD
Albendazole—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000259	0.00179	CcSEcCtD
Albendazole—Headache—Pioglitazone—type 2 diabetes mellitus	0.000259	0.00178	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000259	0.00178	CcSEcCtD
Albendazole—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000258	0.00178	CcSEcCtD
Albendazole—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000257	0.00775	CbGeAlD
Albendazole—Nausea—Glipizide—type 2 diabetes mellitus	0.000257	0.00177	CcSEcCtD
Albendazole—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000256	0.00176	CcSEcCtD
Albendazole—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000255	0.00176	CcSEcCtD
Albendazole—Rash—Glimepiride—type 2 diabetes mellitus	0.000254	0.00175	CcSEcCtD
Albendazole—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000254	0.00175	CcSEcCtD
Albendazole—Rash—Sitagliptin—type 2 diabetes mellitus	0.000253	0.00174	CcSEcCtD
Albendazole—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000253	0.00174	CcSEcCtD
Albendazole—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.000253	0.00174	CcSEcCtD
Albendazole—Headache—Glimepiride—type 2 diabetes mellitus	0.000252	0.00174	CcSEcCtD
Albendazole—Headache—Sitagliptin—type 2 diabetes mellitus	0.000252	0.00173	CcSEcCtD
Albendazole—ABCB1—kidney—type 2 diabetes mellitus	0.000251	0.00758	CbGeAlD
Albendazole—ABCB1—pancreas—type 2 diabetes mellitus	0.00025	0.00753	CbGeAlD
Albendazole—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000245	0.00169	CcSEcCtD
Albendazole—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000245	0.00739	CbGeAlD
Albendazole—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000245	0.00168	CcSEcCtD
Albendazole—Vertigo—Losartan—type 2 diabetes mellitus	0.000244	0.00168	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000244	0.00168	CcSEcCtD
Albendazole—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000244	0.00168	CcSEcCtD
Albendazole—Leukopenia—Losartan—type 2 diabetes mellitus	0.000243	0.00167	CcSEcCtD
Albendazole—Skin disorder—Metformin—type 2 diabetes mellitus	0.000243	0.00167	CcSEcCtD
Albendazole—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000242	0.00166	CcSEcCtD
Albendazole—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00024	0.00166	CcSEcCtD
Albendazole—Nausea—Glimepiride—type 2 diabetes mellitus	0.000239	0.00165	CcSEcCtD
Albendazole—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000239	0.00164	CcSEcCtD
Albendazole—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000237	0.00163	CcSEcCtD
Albendazole—Alopecia—Ramipril—type 2 diabetes mellitus	0.000237	0.00163	CcSEcCtD
Albendazole—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000236	0.00162	CcSEcCtD
Albendazole—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000236	0.00162	CcSEcCtD
Albendazole—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000231	0.00159	CcSEcCtD
Albendazole—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000231	0.00159	CcSEcCtD
Albendazole—Rash—Bromocriptine—type 2 diabetes mellitus	0.000229	0.00158	CcSEcCtD
Albendazole—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000229	0.00158	CcSEcCtD
Albendazole—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000229	0.00158	CcSEcCtD
Albendazole—Headache—Bromocriptine—type 2 diabetes mellitus	0.000228	0.00157	CcSEcCtD
Albendazole—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000226	0.00684	CbGeAlD
Albendazole—CYP3A4—liver—type 2 diabetes mellitus	0.000224	0.00677	CbGeAlD
Albendazole—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000224	0.00154	CcSEcCtD
Albendazole—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000222	0.00153	CcSEcCtD
Albendazole—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00022	0.00151	CcSEcCtD
Albendazole—Urticaria—Valsartan—type 2 diabetes mellitus	0.000218	0.0015	CcSEcCtD
Albendazole—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000217	0.0015	CcSEcCtD
Albendazole—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000217	0.00149	CcSEcCtD
Albendazole—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000216	0.00149	CcSEcCtD
Albendazole—Urticaria—Orlistat—type 2 diabetes mellitus	0.000215	0.00148	CcSEcCtD
Albendazole—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000214	0.00147	CcSEcCtD
Albendazole—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000214	0.00147	CcSEcCtD
Albendazole—Vomiting—Glyburide—type 2 diabetes mellitus	0.000211	0.00146	CcSEcCtD
Albendazole—Rash—Glyburide—type 2 diabetes mellitus	0.00021	0.00144	CcSEcCtD
Albendazole—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000209	0.00144	CcSEcCtD
Albendazole—Vertigo—Ramipril—type 2 diabetes mellitus	0.000209	0.00144	CcSEcCtD
Albendazole—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000209	0.00144	CcSEcCtD
Albendazole—Headache—Glyburide—type 2 diabetes mellitus	0.000208	0.00143	CcSEcCtD
Albendazole—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000204	0.00141	CcSEcCtD
Albendazole—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000202	0.00139	CcSEcCtD
Albendazole—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.0002	0.00137	CcSEcCtD
Albendazole—Urticaria—Metformin—type 2 diabetes mellitus	0.000198	0.00137	CcSEcCtD
Albendazole—Nausea—Glyburide—type 2 diabetes mellitus	0.000197	0.00136	CcSEcCtD
Albendazole—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000197	0.00136	CcSEcCtD
Albendazole—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000197	0.00136	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000197	0.00136	CcSEcCtD
Albendazole—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000193	0.00133	CcSEcCtD
Albendazole—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00019	0.00131	CcSEcCtD
Albendazole—Rash—Gliclazide—type 2 diabetes mellitus	0.000188	0.0013	CcSEcCtD
Albendazole—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000188	0.00129	CcSEcCtD
Albendazole—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000187	0.00129	CcSEcCtD
Albendazole—Headache—Gliclazide—type 2 diabetes mellitus	0.000187	0.00129	CcSEcCtD
Albendazole—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000186	0.00128	CcSEcCtD
Albendazole—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000186	0.00128	CcSEcCtD
Albendazole—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000186	0.00128	CcSEcCtD
Albendazole—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000185	0.00127	CcSEcCtD
Albendazole—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000181	0.00125	CcSEcCtD
Albendazole—Dizziness—Valsartan—type 2 diabetes mellitus	0.000181	0.00125	CcSEcCtD
Albendazole—Dizziness—Orlistat—type 2 diabetes mellitus	0.000179	0.00123	CcSEcCtD
Albendazole—Nausea—Gliclazide—type 2 diabetes mellitus	0.000177	0.00122	CcSEcCtD
Albendazole—Urticaria—Losartan—type 2 diabetes mellitus	0.000176	0.00121	CcSEcCtD
Albendazole—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000175	0.00121	CcSEcCtD
Albendazole—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000175	0.00121	CcSEcCtD
Albendazole—Vomiting—Valsartan—type 2 diabetes mellitus	0.000174	0.0012	CcSEcCtD
Albendazole—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000174	0.0012	CcSEcCtD
Albendazole—Rash—Valsartan—type 2 diabetes mellitus	0.000173	0.00119	CcSEcCtD
Albendazole—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000173	0.00119	CcSEcCtD
Albendazole—Vomiting—Orlistat—type 2 diabetes mellitus	0.000172	0.00119	CcSEcCtD
Albendazole—Headache—Valsartan—type 2 diabetes mellitus	0.000172	0.00118	CcSEcCtD
Albendazole—Rash—Orlistat—type 2 diabetes mellitus	0.000171	0.00118	CcSEcCtD
Albendazole—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000171	0.00118	CcSEcCtD
Albendazole—Headache—Orlistat—type 2 diabetes mellitus	0.00017	0.00117	CcSEcCtD
Albendazole—Dizziness—Metformin—type 2 diabetes mellitus	0.000165	0.00114	CcSEcCtD
Albendazole—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000163	0.00112	CcSEcCtD
Albendazole—Nausea—Valsartan—type 2 diabetes mellitus	0.000163	0.00112	CcSEcCtD
Albendazole—Nausea—Orlistat—type 2 diabetes mellitus	0.000161	0.00111	CcSEcCtD
Albendazole—ABCB1—liver—type 2 diabetes mellitus	0.000159	0.00479	CbGeAlD
Albendazole—Vomiting—Metformin—type 2 diabetes mellitus	0.000159	0.00109	CcSEcCtD
Albendazole—Rash—Metformin—type 2 diabetes mellitus	0.000157	0.00108	CcSEcCtD
Albendazole—Dermatitis—Metformin—type 2 diabetes mellitus	0.000157	0.00108	CcSEcCtD
Albendazole—Headache—Metformin—type 2 diabetes mellitus	0.000156	0.00108	CcSEcCtD
Albendazole—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000156	0.00107	CcSEcCtD
Albendazole—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000156	0.00107	CcSEcCtD
Albendazole—Urticaria—Ramipril—type 2 diabetes mellitus	0.000151	0.00104	CcSEcCtD
Albendazole—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.00015	0.00103	CcSEcCtD
Albendazole—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00015	0.00103	CcSEcCtD
Albendazole—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00015	0.00103	CcSEcCtD
Albendazole—Rash—Irbesartan—type 2 diabetes mellitus	0.000149	0.00102	CcSEcCtD
Albendazole—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000148	0.00102	CcSEcCtD
Albendazole—Nausea—Metformin—type 2 diabetes mellitus	0.000148	0.00102	CcSEcCtD
Albendazole—Headache—Irbesartan—type 2 diabetes mellitus	0.000148	0.00102	CcSEcCtD
Albendazole—Dizziness—Losartan—type 2 diabetes mellitus	0.000147	0.00101	CcSEcCtD
Albendazole—Vomiting—Losartan—type 2 diabetes mellitus	0.000141	0.000971	CcSEcCtD
Albendazole—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00014	0.000965	CcSEcCtD
Albendazole—Nausea—Irbesartan—type 2 diabetes mellitus	0.00014	0.000964	CcSEcCtD
Albendazole—Rash—Losartan—type 2 diabetes mellitus	0.00014	0.000963	CcSEcCtD
Albendazole—Dermatitis—Losartan—type 2 diabetes mellitus	0.00014	0.000962	CcSEcCtD
Albendazole—Headache—Losartan—type 2 diabetes mellitus	0.000139	0.000957	CcSEcCtD
Albendazole—Nausea—Losartan—type 2 diabetes mellitus	0.000132	0.000907	CcSEcCtD
Albendazole—Dizziness—Ramipril—type 2 diabetes mellitus	0.000126	0.000866	CcSEcCtD
Albendazole—Vomiting—Ramipril—type 2 diabetes mellitus	0.000121	0.000832	CcSEcCtD
Albendazole—Rash—Ramipril—type 2 diabetes mellitus	0.00012	0.000826	CcSEcCtD
Albendazole—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00012	0.000825	CcSEcCtD
Albendazole—Headache—Ramipril—type 2 diabetes mellitus	0.000119	0.00082	CcSEcCtD
Albendazole—Nausea—Ramipril—type 2 diabetes mellitus	0.000113	0.000778	CcSEcCtD
Albendazole—CYP1A1—Metabolism—NAMPT—type 2 diabetes mellitus	1.06e-05	0.000186	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	1.06e-05	0.000186	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	1.06e-05	0.000186	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	1.06e-05	0.000186	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	1.06e-05	0.000186	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.06e-05	0.000185	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HBA1—type 2 diabetes mellitus	1.05e-05	0.000185	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—LIPC—type 2 diabetes mellitus	1.05e-05	0.000185	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GCK—type 2 diabetes mellitus	1.05e-05	0.000185	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.05e-05	0.000184	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.05e-05	0.000184	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP11A1—type 2 diabetes mellitus	1.05e-05	0.000184	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	1.03e-05	0.000181	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.03e-05	0.000181	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC9A1—type 2 diabetes mellitus	1.03e-05	0.000181	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CETP—type 2 diabetes mellitus	1.02e-05	0.000179	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	1.02e-05	0.000178	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.01e-05	0.000178	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.01e-05	0.000178	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.01e-05	0.000178	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.01e-05	0.000178	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.01e-05	0.000178	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	1.01e-05	0.000178	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.01e-05	0.000178	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	9.96e-06	0.000175	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	9.96e-06	0.000175	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	9.96e-06	0.000175	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	9.82e-06	0.000172	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	9.7e-06	0.00017	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	9.65e-06	0.000169	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	9.49e-06	0.000167	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PSMD6—type 2 diabetes mellitus	9.46e-06	0.000166	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SREBF1—type 2 diabetes mellitus	9.46e-06	0.000166	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SNAP25—type 2 diabetes mellitus	9.46e-06	0.000166	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	9.45e-06	0.000166	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	9.36e-06	0.000164	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CTGF—type 2 diabetes mellitus	9.29e-06	0.000163	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	9.27e-06	0.000163	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	9.27e-06	0.000163	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	9.22e-06	0.000162	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HMGCR—type 2 diabetes mellitus	9.2e-06	0.000162	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.1e-06	0.00016	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.08e-06	0.000159	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	9.04e-06	0.000159	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ADRA2A—type 2 diabetes mellitus	9.01e-06	0.000158	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	8.99e-06	0.000158	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	8.82e-06	0.000155	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	8.77e-06	0.000154	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	8.76e-06	0.000154	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP2E1—type 2 diabetes mellitus	8.65e-06	0.000152	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	8.65e-06	0.000152	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	8.65e-06	0.000152	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	8.62e-06	0.000151	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	8.62e-06	0.000151	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	8.62e-06	0.000151	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC2A1—type 2 diabetes mellitus	8.56e-06	0.00015	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP1A2—type 2 diabetes mellitus	8.56e-06	0.00015	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	8.48e-06	0.000149	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	8.47e-06	0.000149	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	8.47e-06	0.000149	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	8.47e-06	0.000149	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	8.47e-06	0.000149	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	8.43e-06	0.000148	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	8.43e-06	0.000148	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	8.43e-06	0.000148	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	8.37e-06	0.000147	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CYP3A4—type 2 diabetes mellitus	8.34e-06	0.000146	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	8.3e-06	0.000146	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	8.27e-06	0.000145	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	8.27e-06	0.000145	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	8.22e-06	0.000144	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	8.2e-06	0.000144	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GCG—type 2 diabetes mellitus	8.2e-06	0.000144	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	8.14e-06	0.000143	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	8.13e-06	0.000143	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	8.12e-06	0.000142	CbGpPWpGaD
Albendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	7.98e-06	0.00014	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	7.96e-06	0.00014	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	7.96e-06	0.00014	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	7.88e-06	0.000138	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	7.82e-06	0.000137	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	7.73e-06	0.000136	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	7.68e-06	0.000135	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	7.68e-06	0.000135	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	7.68e-06	0.000135	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	7.64e-06	0.000134	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	7.56e-06	0.000133	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	7.56e-06	0.000133	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	7.56e-06	0.000133	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	7.55e-06	0.000132	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	7.42e-06	0.00013	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	7.35e-06	0.000129	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	7.22e-06	0.000127	CbGpPWpGaD
Albendazole—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.21e-06	0.000126	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	7.19e-06	0.000126	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.07e-06	0.000124	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GNB3—type 2 diabetes mellitus	7.07e-06	0.000124	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	7.04e-06	0.000124	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—HMOX1—type 2 diabetes mellitus	7.04e-06	0.000124	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CAT—type 2 diabetes mellitus	6.94e-06	0.000122	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	6.91e-06	0.000121	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	6.9e-06	0.000121	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	6.9e-06	0.000121	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	6.83e-06	0.00012	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	6.83e-06	0.00012	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	6.77e-06	0.000119	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	6.77e-06	0.000119	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOB—type 2 diabetes mellitus	6.74e-06	0.000118	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	6.73e-06	0.000118	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	6.73e-06	0.000118	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	6.73e-06	0.000118	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	6.73e-06	0.000118	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	6.68e-06	0.000117	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	6.66e-06	0.000117	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	6.56e-06	0.000115	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GSTM1—type 2 diabetes mellitus	6.56e-06	0.000115	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	6.55e-06	0.000115	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	6.55e-06	0.000115	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	6.53e-06	0.000115	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	6.53e-06	0.000115	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	6.53e-06	0.000115	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	6.53e-06	0.000115	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	6.49e-06	0.000114	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	6.44e-06	0.000113	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	6.3e-06	0.000111	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	6.28e-06	0.00011	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	6.26e-06	0.00011	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	6.12e-06	0.000107	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.05e-06	0.000106	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	6.04e-06	0.000106	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	6.03e-06	0.000106	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	6.03e-06	0.000106	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	6.03e-06	0.000106	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	5.92e-06	0.000104	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	5.87e-06	0.000103	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.82e-06	0.000102	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	5.8e-06	0.000102	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	5.79e-06	0.000102	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	5.74e-06	0.000101	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	5.69e-06	9.98e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	5.65e-06	9.91e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.65e-06	9.91e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	5.62e-06	9.87e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	5.55e-06	9.74e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	5.52e-06	9.68e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	5.51e-06	9.67e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	5.46e-06	9.58e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	5.44e-06	9.54e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	5.41e-06	9.5e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	5.4e-06	9.47e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	5.38e-06	9.45e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	5.33e-06	9.36e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	5.33e-06	9.35e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	5.33e-06	9.35e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	5.32e-06	9.34e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.29e-06	9.29e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	5.24e-06	9.19e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	5.23e-06	9.18e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	5.23e-06	9.18e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	5.22e-06	9.17e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	5.19e-06	9.11e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	5.19e-06	9.11e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	5.19e-06	9.11e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	5.16e-06	9.05e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	5.14e-06	9.02e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	5.07e-06	8.89e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	5.03e-06	8.83e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	5.02e-06	8.8e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	5.01e-06	8.79e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	4.89e-06	8.57e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	4.82e-06	8.47e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	4.7e-06	8.25e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.66e-06	8.17e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.66e-06	8.17e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.66e-06	8.17e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	4.63e-06	8.13e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	4.61e-06	8.09e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.57e-06	8.02e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	4.54e-06	7.97e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.53e-06	7.95e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	4.51e-06	7.91e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.51e-06	7.91e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	4.49e-06	7.88e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	4.43e-06	7.78e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	4.43e-06	7.77e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	4.4e-06	7.72e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	4.32e-06	7.59e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	4.31e-06	7.56e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	4.3e-06	7.54e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	4.26e-06	7.48e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	4.26e-06	7.47e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	4.23e-06	7.42e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	4.21e-06	7.39e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	4.21e-06	7.39e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	4.18e-06	7.34e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	4.1e-06	7.2e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	4.04e-06	7.09e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	4.04e-06	7.09e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	4.04e-06	7.09e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	4.04e-06	7.09e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.02e-06	7.05e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	4e-06	7.03e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	3.9e-06	6.84e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.85e-06	6.76e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.75e-06	6.59e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	3.7e-06	6.49e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	3.7e-06	6.49e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.68e-06	6.46e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	3.63e-06	6.36e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3.51e-06	6.16e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.48e-06	6.11e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.48e-06	6.11e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.46e-06	6.08e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	3.45e-06	6.06e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	3.44e-06	6.04e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.42e-06	6e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	3.4e-06	5.97e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	3.38e-06	5.92e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	3.32e-06	5.82e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	3.23e-06	5.67e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	3.23e-06	5.67e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	3.23e-06	5.66e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	3.17e-06	5.56e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	3.1e-06	5.44e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	3.09e-06	5.42e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	3.01e-06	5.28e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3e-06	5.26e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.97e-06	5.22e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.95e-06	5.18e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	2.94e-06	5.16e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.85e-06	5.01e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.8e-06	4.91e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.71e-06	4.76e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	2.69e-06	4.73e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.66e-06	4.68e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.66e-06	4.66e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.62e-06	4.61e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.58e-06	4.52e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.58e-06	4.52e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.36e-06	4.14e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.31e-06	4.06e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.27e-06	3.98e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.08e-06	3.65e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.99e-06	3.49e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.99e-06	3.49e-05	CbGpPWpGaD
Albendazole—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	1.86e-06	3.26e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.82e-06	3.19e-05	CbGpPWpGaD
Albendazole—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.48e-06	2.6e-05	CbGpPWpGaD
Albendazole—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.18e-06	2.08e-05	CbGpPWpGaD
Albendazole—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	9.14e-07	1.6e-05	CbGpPWpGaD
